Loading…

Computed Tomography (CT)-Guided Needle Biopsy of Lung Lesions: A Single Center Experience

(1) : Lung cancer is one of the leading causes of cancer death among men and women across the globe. The accurate and timely diagnosis of lung lesions is of paramount importance for prognosis. This single-center study is the first to assess the diagnostic yield and complication rate of a computed to...

Full description

Saved in:
Bibliographic Details
Published in:Healthcare (Basel) 2024-07, Vol.12 (13), p.1260
Main Authors: Ezenagu, Oluebube C, Gabriel, Gaby E, Saha, Sibu P
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c389t-6497c98c0e9354e25c1af863312e568bc79c0c76773e20466e5a9a531a00440b3
container_end_page
container_issue 13
container_start_page 1260
container_title Healthcare (Basel)
container_volume 12
creator Ezenagu, Oluebube C
Gabriel, Gaby E
Saha, Sibu P
description (1) : Lung cancer is one of the leading causes of cancer death among men and women across the globe. The accurate and timely diagnosis of lung lesions is of paramount importance for prognosis. This single-center study is the first to assess the diagnostic yield and complication rate of a computed tomography (CT)-guided needle biopsy of pulmonary parenchymal and pleural nodules in an academic training center in the United States. (2) : This is a retrospective study approved by IRB. Patients who underwent CT-guided needle biopsy between 2016 and 2020 were reviewed. A CT-guided needle biopsy involving mediastinal lesions was excluded, focusing only on lung parenchymal and pleural lesions. A CT-guided needle biopsy aborted at any point during the procedure was also excluded from this study. (3) : 1063 patients were included in this study; 532 were males, and 531 were females. Lesion size ranged from 0.26 cm to 9.2 cm. 1040 patients received diagnoses, among which 772 had a specific diagnosis, and 268 had nonspecific inflammatory or non-malignant diagnoses. Twenty-three cases were non-diagnostic. Among the patients with specific diagnoses, 691 were malignant, 5 were hamartomas, 30 were fungal infections, 6 were acid-fast-positive organisms, and 40 were unspecified atypical cells. Of the patients that had a malignant diagnosis, 317 were adenocarcinoma, 197 were squamous cell carcinoma, 26 were a neuroendocrine tumor, 45 were non-small cell carcinoma (undifferentiated), 17 were small cell carcinoma, and 89 were other metastatic malignancies to the lung. Various common complications, including pneumothorax (337), hemorrhage (128), and hemoptysis (17), were observed, and 42 of the cases required chest tube intervention; others were treated with observation. Other rare complications observed included hemothorax (4) and oxygen desaturation (2), and there was no death in this series. (4) : CT-guided needle biopsy is a reliable diagnostic modality for patients with lung parenchymal and pleural nodules, and it can effectively distinguish between benign and cancerous lesions before invasive procedures such as video-assisted thoracoscopy (VATs) or thoracotomy are planned. Our study showed a higher rate of pneumothorax and pulmonary hemorrhage compared to the rates established in guidelines, attributable to the varying experience level in a busy training academic center.
doi_str_mv 10.3390/healthcare12131260
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_be4de7206fc44d65bb1536350028d00d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A801334789</galeid><doaj_id>oai_doaj_org_article_be4de7206fc44d65bb1536350028d00d</doaj_id><sourcerecordid>A801334789</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-6497c98c0e9354e25c1af863312e568bc79c0c76773e20466e5a9a531a00440b3</originalsourceid><addsrcrecordid>eNptkktv1DAUhSMEolXpH2CBIrEpixQ_4he7ISql0ggWDAtWlmPfzHiUxMFOJObf42FKedoLW1ffOb7HukXxHKNrShV6vQPTzztrImCCKSYcPSrOCSGiUoiSx7_dz4rLlPYoL4WppOxpcUalUlIofl58acIwLTO4chOGsI1m2h3Kq2bzqrpdvMvlDwCuh_KtD1M6lKEr18u4LdeQfBjTm3JVfvLjNgMNjDPE8ubbBNHDaOFZ8aQzfYLL-_Oi-PzuZtO8r9Yfb--a1bqyuYu54rUSVkmLQFFWA2EWm05ymiMB47K1QllkBReCAkE158CMMoxig1Bdo5ZeFHcnXxfMXk_RDyYedDBe_yiEuNUmzt72oFuoHQiCeGfr2nHWtphRThlCRDqEXPa6OnlNMXxdIM168MlC35sRwpI0RUJJJrGkGX35F7oPSxxz0iOV_5cRJX5RW5Pf92MX5mjs0VSvJMKU1hnN1PV_qLwdDN6GETqf638IyElgY0gpQveQGyN9HA_973hk0Yv7jpd2APcg-TkM9DtBV7KS</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3078995297</pqid></control><display><type>article</type><title>Computed Tomography (CT)-Guided Needle Biopsy of Lung Lesions: A Single Center Experience</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Ezenagu, Oluebube C ; Gabriel, Gaby E ; Saha, Sibu P</creator><creatorcontrib>Ezenagu, Oluebube C ; Gabriel, Gaby E ; Saha, Sibu P</creatorcontrib><description>(1) : Lung cancer is one of the leading causes of cancer death among men and women across the globe. The accurate and timely diagnosis of lung lesions is of paramount importance for prognosis. This single-center study is the first to assess the diagnostic yield and complication rate of a computed tomography (CT)-guided needle biopsy of pulmonary parenchymal and pleural nodules in an academic training center in the United States. (2) : This is a retrospective study approved by IRB. Patients who underwent CT-guided needle biopsy between 2016 and 2020 were reviewed. A CT-guided needle biopsy involving mediastinal lesions was excluded, focusing only on lung parenchymal and pleural lesions. A CT-guided needle biopsy aborted at any point during the procedure was also excluded from this study. (3) : 1063 patients were included in this study; 532 were males, and 531 were females. Lesion size ranged from 0.26 cm to 9.2 cm. 1040 patients received diagnoses, among which 772 had a specific diagnosis, and 268 had nonspecific inflammatory or non-malignant diagnoses. Twenty-three cases were non-diagnostic. Among the patients with specific diagnoses, 691 were malignant, 5 were hamartomas, 30 were fungal infections, 6 were acid-fast-positive organisms, and 40 were unspecified atypical cells. Of the patients that had a malignant diagnosis, 317 were adenocarcinoma, 197 were squamous cell carcinoma, 26 were a neuroendocrine tumor, 45 were non-small cell carcinoma (undifferentiated), 17 were small cell carcinoma, and 89 were other metastatic malignancies to the lung. Various common complications, including pneumothorax (337), hemorrhage (128), and hemoptysis (17), were observed, and 42 of the cases required chest tube intervention; others were treated with observation. Other rare complications observed included hemothorax (4) and oxygen desaturation (2), and there was no death in this series. (4) : CT-guided needle biopsy is a reliable diagnostic modality for patients with lung parenchymal and pleural nodules, and it can effectively distinguish between benign and cancerous lesions before invasive procedures such as video-assisted thoracoscopy (VATs) or thoracotomy are planned. Our study showed a higher rate of pneumothorax and pulmonary hemorrhage compared to the rates established in guidelines, attributable to the varying experience level in a busy training academic center.</description><identifier>ISSN: 2227-9032</identifier><identifier>EISSN: 2227-9032</identifier><identifier>DOI: 10.3390/healthcare12131260</identifier><identifier>PMID: 38998796</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Biopsy ; Biopsy, Needle ; Bronchoscopy ; Cellular biology ; complication rate ; CT imaging ; CT-guided needle biopsy ; Diagnosis ; diagnostic rate ; Lung cancer ; Lung diseases ; lung lesions ; Medical research ; Medical screening ; Medicine, Experimental ; Methods ; Ostomy ; Patients ; Pneumothorax ; pulmonary lesions ; Tomography ; transthoracic needle biopsy</subject><ispartof>Healthcare (Basel), 2024-07, Vol.12 (13), p.1260</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c389t-6497c98c0e9354e25c1af863312e568bc79c0c76773e20466e5a9a531a00440b3</cites><orcidid>0000-0003-4573-7041 ; 0009-0000-8088-507X ; 0000-0003-4275-3265</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3078995297/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3078995297?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,44590,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38998796$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ezenagu, Oluebube C</creatorcontrib><creatorcontrib>Gabriel, Gaby E</creatorcontrib><creatorcontrib>Saha, Sibu P</creatorcontrib><title>Computed Tomography (CT)-Guided Needle Biopsy of Lung Lesions: A Single Center Experience</title><title>Healthcare (Basel)</title><addtitle>Healthcare (Basel)</addtitle><description>(1) : Lung cancer is one of the leading causes of cancer death among men and women across the globe. The accurate and timely diagnosis of lung lesions is of paramount importance for prognosis. This single-center study is the first to assess the diagnostic yield and complication rate of a computed tomography (CT)-guided needle biopsy of pulmonary parenchymal and pleural nodules in an academic training center in the United States. (2) : This is a retrospective study approved by IRB. Patients who underwent CT-guided needle biopsy between 2016 and 2020 were reviewed. A CT-guided needle biopsy involving mediastinal lesions was excluded, focusing only on lung parenchymal and pleural lesions. A CT-guided needle biopsy aborted at any point during the procedure was also excluded from this study. (3) : 1063 patients were included in this study; 532 were males, and 531 were females. Lesion size ranged from 0.26 cm to 9.2 cm. 1040 patients received diagnoses, among which 772 had a specific diagnosis, and 268 had nonspecific inflammatory or non-malignant diagnoses. Twenty-three cases were non-diagnostic. Among the patients with specific diagnoses, 691 were malignant, 5 were hamartomas, 30 were fungal infections, 6 were acid-fast-positive organisms, and 40 were unspecified atypical cells. Of the patients that had a malignant diagnosis, 317 were adenocarcinoma, 197 were squamous cell carcinoma, 26 were a neuroendocrine tumor, 45 were non-small cell carcinoma (undifferentiated), 17 were small cell carcinoma, and 89 were other metastatic malignancies to the lung. Various common complications, including pneumothorax (337), hemorrhage (128), and hemoptysis (17), were observed, and 42 of the cases required chest tube intervention; others were treated with observation. Other rare complications observed included hemothorax (4) and oxygen desaturation (2), and there was no death in this series. (4) : CT-guided needle biopsy is a reliable diagnostic modality for patients with lung parenchymal and pleural nodules, and it can effectively distinguish between benign and cancerous lesions before invasive procedures such as video-assisted thoracoscopy (VATs) or thoracotomy are planned. Our study showed a higher rate of pneumothorax and pulmonary hemorrhage compared to the rates established in guidelines, attributable to the varying experience level in a busy training academic center.</description><subject>Biopsy</subject><subject>Biopsy, Needle</subject><subject>Bronchoscopy</subject><subject>Cellular biology</subject><subject>complication rate</subject><subject>CT imaging</subject><subject>CT-guided needle biopsy</subject><subject>Diagnosis</subject><subject>diagnostic rate</subject><subject>Lung cancer</subject><subject>Lung diseases</subject><subject>lung lesions</subject><subject>Medical research</subject><subject>Medical screening</subject><subject>Medicine, Experimental</subject><subject>Methods</subject><subject>Ostomy</subject><subject>Patients</subject><subject>Pneumothorax</subject><subject>pulmonary lesions</subject><subject>Tomography</subject><subject>transthoracic needle biopsy</subject><issn>2227-9032</issn><issn>2227-9032</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkktv1DAUhSMEolXpH2CBIrEpixQ_4he7ISql0ggWDAtWlmPfzHiUxMFOJObf42FKedoLW1ffOb7HukXxHKNrShV6vQPTzztrImCCKSYcPSrOCSGiUoiSx7_dz4rLlPYoL4WppOxpcUalUlIofl58acIwLTO4chOGsI1m2h3Kq2bzqrpdvMvlDwCuh_KtD1M6lKEr18u4LdeQfBjTm3JVfvLjNgMNjDPE8ubbBNHDaOFZ8aQzfYLL-_Oi-PzuZtO8r9Yfb--a1bqyuYu54rUSVkmLQFFWA2EWm05ymiMB47K1QllkBReCAkE158CMMoxig1Bdo5ZeFHcnXxfMXk_RDyYedDBe_yiEuNUmzt72oFuoHQiCeGfr2nHWtphRThlCRDqEXPa6OnlNMXxdIM168MlC35sRwpI0RUJJJrGkGX35F7oPSxxz0iOV_5cRJX5RW5Pf92MX5mjs0VSvJMKU1hnN1PV_qLwdDN6GETqf638IyElgY0gpQveQGyN9HA_973hk0Yv7jpd2APcg-TkM9DtBV7KS</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Ezenagu, Oluebube C</creator><creator>Gabriel, Gaby E</creator><creator>Saha, Sibu P</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>KB0</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4573-7041</orcidid><orcidid>https://orcid.org/0009-0000-8088-507X</orcidid><orcidid>https://orcid.org/0000-0003-4275-3265</orcidid></search><sort><creationdate>20240701</creationdate><title>Computed Tomography (CT)-Guided Needle Biopsy of Lung Lesions: A Single Center Experience</title><author>Ezenagu, Oluebube C ; Gabriel, Gaby E ; Saha, Sibu P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-6497c98c0e9354e25c1af863312e568bc79c0c76773e20466e5a9a531a00440b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biopsy</topic><topic>Biopsy, Needle</topic><topic>Bronchoscopy</topic><topic>Cellular biology</topic><topic>complication rate</topic><topic>CT imaging</topic><topic>CT-guided needle biopsy</topic><topic>Diagnosis</topic><topic>diagnostic rate</topic><topic>Lung cancer</topic><topic>Lung diseases</topic><topic>lung lesions</topic><topic>Medical research</topic><topic>Medical screening</topic><topic>Medicine, Experimental</topic><topic>Methods</topic><topic>Ostomy</topic><topic>Patients</topic><topic>Pneumothorax</topic><topic>pulmonary lesions</topic><topic>Tomography</topic><topic>transthoracic needle biopsy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ezenagu, Oluebube C</creatorcontrib><creatorcontrib>Gabriel, Gaby E</creatorcontrib><creatorcontrib>Saha, Sibu P</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Healthcare (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ezenagu, Oluebube C</au><au>Gabriel, Gaby E</au><au>Saha, Sibu P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Computed Tomography (CT)-Guided Needle Biopsy of Lung Lesions: A Single Center Experience</atitle><jtitle>Healthcare (Basel)</jtitle><addtitle>Healthcare (Basel)</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>12</volume><issue>13</issue><spage>1260</spage><pages>1260-</pages><issn>2227-9032</issn><eissn>2227-9032</eissn><abstract>(1) : Lung cancer is one of the leading causes of cancer death among men and women across the globe. The accurate and timely diagnosis of lung lesions is of paramount importance for prognosis. This single-center study is the first to assess the diagnostic yield and complication rate of a computed tomography (CT)-guided needle biopsy of pulmonary parenchymal and pleural nodules in an academic training center in the United States. (2) : This is a retrospective study approved by IRB. Patients who underwent CT-guided needle biopsy between 2016 and 2020 were reviewed. A CT-guided needle biopsy involving mediastinal lesions was excluded, focusing only on lung parenchymal and pleural lesions. A CT-guided needle biopsy aborted at any point during the procedure was also excluded from this study. (3) : 1063 patients were included in this study; 532 were males, and 531 were females. Lesion size ranged from 0.26 cm to 9.2 cm. 1040 patients received diagnoses, among which 772 had a specific diagnosis, and 268 had nonspecific inflammatory or non-malignant diagnoses. Twenty-three cases were non-diagnostic. Among the patients with specific diagnoses, 691 were malignant, 5 were hamartomas, 30 were fungal infections, 6 were acid-fast-positive organisms, and 40 were unspecified atypical cells. Of the patients that had a malignant diagnosis, 317 were adenocarcinoma, 197 were squamous cell carcinoma, 26 were a neuroendocrine tumor, 45 were non-small cell carcinoma (undifferentiated), 17 were small cell carcinoma, and 89 were other metastatic malignancies to the lung. Various common complications, including pneumothorax (337), hemorrhage (128), and hemoptysis (17), were observed, and 42 of the cases required chest tube intervention; others were treated with observation. Other rare complications observed included hemothorax (4) and oxygen desaturation (2), and there was no death in this series. (4) : CT-guided needle biopsy is a reliable diagnostic modality for patients with lung parenchymal and pleural nodules, and it can effectively distinguish between benign and cancerous lesions before invasive procedures such as video-assisted thoracoscopy (VATs) or thoracotomy are planned. Our study showed a higher rate of pneumothorax and pulmonary hemorrhage compared to the rates established in guidelines, attributable to the varying experience level in a busy training academic center.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38998796</pmid><doi>10.3390/healthcare12131260</doi><orcidid>https://orcid.org/0000-0003-4573-7041</orcidid><orcidid>https://orcid.org/0009-0000-8088-507X</orcidid><orcidid>https://orcid.org/0000-0003-4275-3265</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2227-9032
ispartof Healthcare (Basel), 2024-07, Vol.12 (13), p.1260
issn 2227-9032
2227-9032
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_be4de7206fc44d65bb1536350028d00d
source PubMed Central Free; Publicly Available Content Database
subjects Biopsy
Biopsy, Needle
Bronchoscopy
Cellular biology
complication rate
CT imaging
CT-guided needle biopsy
Diagnosis
diagnostic rate
Lung cancer
Lung diseases
lung lesions
Medical research
Medical screening
Medicine, Experimental
Methods
Ostomy
Patients
Pneumothorax
pulmonary lesions
Tomography
transthoracic needle biopsy
title Computed Tomography (CT)-Guided Needle Biopsy of Lung Lesions: A Single Center Experience
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T21%3A52%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Computed%20Tomography%20(CT)-Guided%20Needle%20Biopsy%20of%20Lung%20Lesions:%20A%20Single%20Center%20Experience&rft.jtitle=Healthcare%20(Basel)&rft.au=Ezenagu,%20Oluebube%20C&rft.date=2024-07-01&rft.volume=12&rft.issue=13&rft.spage=1260&rft.pages=1260-&rft.issn=2227-9032&rft.eissn=2227-9032&rft_id=info:doi/10.3390/healthcare12131260&rft_dat=%3Cgale_doaj_%3EA801334789%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c389t-6497c98c0e9354e25c1af863312e568bc79c0c76773e20466e5a9a531a00440b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3078995297&rft_id=info:pmid/38998796&rft_galeid=A801334789&rfr_iscdi=true